Back
Compare AU
Compare DTEC vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Global X Defence Tech ETF (DTEC) and the Betashares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DTEC | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 180 | 75 |
Median incremental investment | $993.50 | $742.79 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,359.26 | $1,802.00 |
Average age group | > 35 | > 35 |
Key Summary
DTEC | DRUG | |
|---|---|---|
Strategy | DTEC.AX was created on 2024-10-07 by Global X. The fund's investment portfolio concentrates primarily on industrials equity. The investment objective of the Fund is to provide investors with a return that (before fees and expenses) tracks the performance of the Global X Defense Tech Index. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | Lockheed Martin Corp (8.99 %) RTX Corp (7.95 %) General Dynamics Corp (6.89 %) | BRL - BRAZILIAN REAL (0 %) AUD - AUSTRALIA DOLLAR (0 %) CHF - SWISS FRANC (0 %) |
Top 3 industries | Industrials (84.07 %) Information Technology (15.93 %) | Other (75.91 %) Communication Services (33.53 %) Health Care (23.80 %) |
Top 3 countries | United States (59.63 %) Germany (8.21 %) Korea (6.97 %) | United States (69.91 %) Switzerland (10.93 %) United Kingdom of Great Britain and Northern Ireland (7.38 %) |
Management fee | 0.51 % | 0.57 % |
Key Summary
DTEC | DRUG | |
|---|---|---|
Issuer | Global X | BetaShares |
Tracking index | Global X Defense Tech Index - Benchmark TR Net | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.51 % | 0.57 % |
Price | $18.31 | $8.45 |
Size | $142.320 million | $163.973 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 0.09 % | 1.92 % |
Market | ASX | ASX |
First listed date | 08/10/2024 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DTEC | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 180 | 75 |
Median incremental investment | $993.50 | $742.79 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,359.26 | $1,802.00 |
Average age group | > 35 | > 35 |
Pros and Cons
DTEC | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DTEC | DRUG |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |